Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Respiratory Stress Test Quickly Detects Coronary Artery Disease

By HospiMedica International staff writers
Posted on 15 Mar 2010
A novel, noninvasive respiratory modulation response (RMR) test quickly and accurately detects the presence of significant coronary artery disease (sCAD).

Researchers at the Rabin Medical Center (Petah Tikva, Israel) tested a proprietary respiratory stress test based on pulse oximetry photoplethysmograph (PPG) readings on 97 consecutive patients referred for coronary angiography to exclude sCAD; mean patient age was 62, and most were men (77%). More...
The PPG reading measured blood flow in the finger after 20 seconds of spontaneous breathing, followed by 70 seconds of paced breathing at 0.1 Hz; the data was captured and recorded immediately, and then processed using a spectral analysis algorithm that determined the RMR in a percentage value. Coronary angiography was performed on all subjects and analyzed by cardiologists who were blinded to the RMR results; coronary lesions with diameter stenosis of over 50% that required revascularization were classified significant.

The researcher found that patients in the study with sCAD had a lower RMR compared to patients with nonsignificant CAD, regardless of individual risk factors or previous clinical history of angina, myocardial infarction (MI), or angioplasty. Using receiver operating characteristic analysis, the researcher identified an RMR value lower than 30% to be the optimal cutoff for predicting significant CAD. There were no significant differences between patients with sCAD and those with non-sCAD with respect to the risk factors, apart from the fact that patients with sCAD had more incidences of recent (MI), while patients without sCAD did not. No side effects were reported. The study was published in the February 2010 issue of Euro Intervention Journal.

"Identifying significant coronary artery disease through noninvasive testing is very challenging,” said coauthor Ran Kornowski, M.D., director of the department of interventional cardiology.” This study shows that the Spirocor test is a simple and noninvasive test that independently predicts significant coronary artery disease in patients referred for a coronary artery evaluation.”

The proprietary respiratory stress test system was developed by Spirocor (Tel Aviv, Israel). The noninvasive PPG finger probe is connected to a computer with analyzing software residing on a central server, accessed via the internet. The patient performs a controlled breathing exercise, which consists of inhaling, and exhaling seven times; the PPG signal is automatically captured and the data transmitted for analysis and determination of the RMR. A report is automatically generated and made available on a password secured Web site for the cardiologist to review and make a decision regarding future diagnostic and therapeutic steps.

Related Links:

Rabin Medical Center
Spirocor



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.